Laws, Acts, and Legislation

SCR 40
As Introduced

View Full Text

(.pdf format)

(.html format)

View Publications Associated with this Resolution

Resolution Analyses

Synopsis of Committee Amendments

Conference Committee Synopsis

Fiscal Notes

Status Report of Legislation

Votes

Other Versions of Resolution and Associated Reports

The online versions of legislation provided on this website are not official. Enrolled bills are the final version passed by the Ohio General Assembly and presented to the Governor for signature. The official version of acts signed by the Governor are available from the Secretary of State's Office in the Continental Plaza, 180 East Broad St., Columbus.

S. C. R. No. 40 As Introduced

As Introduced

130th General Assembly

Regular Session

2013-2014

S. C. R. No. 40

Senator Gentile

Cosponsors: Senators Cafaro, Balderson, Turner, Schiavoni, Kearney

A CONCURRENT RESOLUTION

To urge the Congress of the United States to mitigate the debilitative effects of type 1 diabetes and excessive future health care costs by increasing funding to the National Institutes of Health for research to promote the widespread and affordable availability of a closed-loop diabetic system, referred to as the "artificial pancreas," and islet cell transplantation.

BE IT RESOLVED BY THE SENATE OF THE STATE OF OHIO
(THE HOUSE OF REPRESENTATIVES CONCURRING):

       WHEREAS, More than one million Americans have been diagnosed with insulin-dependent diabetes mellitus, otherwise known as type 1 diabetes; and

       WHEREAS, Type 1 diabetes is a disease that frequently strikes children suddenly, makes them insulin dependent for life, and carries the constant threat of life-threatening complications; and

       WHEREAS, The number of diagnoses of type 1 diabetes is growing at an alarming rate; and

       WHEREAS, The cost of type 1 diabetes, including medical expenses and lost productivity, is billions of dollars per year; and

       WHEREAS, Type 1 diabetes is a leading cause of blindness, kidney failure, amputations, heart disease, and death; and

       WHEREAS, Medical and technological advances in the development of the closed-loop insulin delivery system and islet cell transplantation have created meaningful and realistic pathways to a cure of type 1 diabetes; and

       WHEREAS, Adequate funding for research and development of the closed-loop system and islet cell transplantation will result in positive medical outcomes for millions of Americans who are affected by type 1 diabetes and thereby ameliorate widespread human suffering and preserve billions of dollars in tax payer funds; and

       WHEREAS, Current levels of NIH funding designated for advancing the technology associated with the closed-loop system and islet cell transplantation are inadequate and an increase in funding will expedite the refining of and access to these important medical technologies; now therefore be it

       RESOLVED, That we, the members of the 130th General Assembly of the State of Ohio, in adopting this resolution, urge the Congress of the United States to increase funding levels for research and development of the closed-loop system and islet cell transplantation so that those suffering from type 1 diabetes will have expedited access to such technology, thus enhancing health care while saving billions of dollars in health care costs and lost productivity; and be it further

       RESOLVED, That the Clerk of the Senate transmit duly authenticated copies of this resolution to the President Pro Tempore and Secretary of the United States Senate, the Speaker and Clerk of the United States House of Representatives, and each member of the Ohio Congressional delegation.